JGJulia Granerod

Julia Granerod

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Granerod has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • N. S. Crowcroft

    Virus Reference Department, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom

    3 shared publications
  • Tom Solomon

    The Pandemic Institute, Liverpool L69 7BE, UK; National Institute for Health and Care Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK; Walton Centre NHS Foundation Trust, Liverpool, UK; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Ecological, and Veterinary Sciences, University of Liverpool, Liverpool, UK

    3 shared publications
  • Christopher Meaney

    Department of Family and Community Medicine, University of Toronto, Toronto, Canada

    2 shared publications
  • D. W. G. Brown

    Virus Reference Department, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom

    2 shared publications
  • H. E. Ambrose

    Virus Reference Department, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom

    2 shared publications
  • J. P. Clewley

    Virus Reference Department, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom

    2 shared publications

Latest Publications

  • Encephalitis: recent advances and challenges ahead

    by Julia Granerod, Nicholas Davies

    One reason for the increased interest in encephalitis is the recognition that it is a sentinel condition for new and emerging infections

  • Diagnostic Strategy Used To Establish Etiologies of Encephalitis in a Prospective Cohort of Patients in England

    by H. E. Ambrose, J. Granerod, J. P. Clewley, N. W. S. Davies, G. Keir, R. Cunningham, M. Zuckerman, K. J. Mutton, K. N. Ward, S. Ijaz, et al.

    The laboratory diagnostic strategy used to determine the etiology of encephalitis in 203 patients is reported. An etiological diagnosis was made by first-line laboratory testing for 111 (55%) patients. Subsequent testing, based on individual case reviews, resulted in 17 (8%) further diagnoses, of which 12 (71%) were immune-mediated and 5 (29%) were due to infection. Seventy-five cases were of unknown etiology. Sixteen (8%) of 203 samples were found to be associated with either N -methyl- d -aspartate receptor or voltage-gated potassium channel complex antibodies. The most common viral causes identified were herpes simplex virus (HSV) (19%) and varicella-zoster virus (5%), while the most important bacterial cause was Mycobacterium tuberculosis (5%). The diagnostic value of testing cerebrospinal fluid (CSF) for antibody was assessed using 139 samples from 99 patients, and antibody was detected in 46 samples from 37 patients. Samples collected at 14 to 28 days were more likely to be positive than samples taken 0 to 6 days postadmission. Three PCR-negative HSV cases were diagnosed by the presence of virus-specific antibody in the central nervous system (CNS). It was not possible to make an etiological diagnosis for one-third of the cases; these were therefore considered to be due to unknown causes. Delayed sampling did not contribute to these cases. Twenty percent of the patients with infections with an unknown etiology showed evidence of localized immune activation within the CNS, but no novel viral DNA or RNA sequences were found. We conclude that a good standard of clinical investigation and thorough first-line laboratory testing allows the diagnosis of most cases of infectious encephalitis; testing for CSF antibodies allows further cases to be diagnosed. It is important that testing for immune-mediated causes also be included in a diagnostic algorithm.


  • Open Access

    Potential risk factors associated with human encephalitis: application of canonical correlation analysis

    by the UK Health Protection Agency Aetiology of Encephalitis Study Group, Jemila S Hamid, Christopher Meaney, Natasha S Crowcroft, Julia Granerod, Joseph Beyene

    Infection of the CNS is considered to be the major cause of encephalitis and more than 100 different pathogens have been recognized as causative agents. Despite being identified worldwide as an important public health concern, studies on encephalitis are very few and often focus on particular types (with respect to causative agents) of encephalitis (e.g. West Nile, Japanese, etc.). Moreover, a number of other infectious and non-infectious conditions present with similar symptoms, and distinguishing encephalitis from other disguising conditions continues to a challenging task.


  • Open Access

    Cluster analysis for identifying sub-groups and selecting potential discriminatory variables in human encephalitis

    by Jemila S Hamid, Christopher Meaney, Natasha S Crowcroft, Julia Granerod, Joseph Beyene

    Background: Encephalitis is an acute clinical syndrome of the central nervous system (CNS), often associated with fatal outcome or permanent damage, including cognitive and behavioural impairment, affective disorders and epileptic seizures. Infection of the central nervous system is considered to be a major cause of encephalitis and more than 100 different pathogens have been recognized as causative agents. However, a large proportion of cases have unknown disease etiology. Methods: We perform hierarchical cluster analysis on a multicenter England encephalitis data set with the aim of identifying sub-groups in human encephalitis. We use the simple matching similarity measure which is appropriate for binary data sets and performed variable selection using cluster heatmaps. We also use heatmaps to visually assess underlying patterns in the data, identify the main clinical and laboratory features and identify potential risk factors associated with encephalitis. Results: Our results identified fever, personality and behavioural change, headache and lethargy as the main characteristics of encephalitis. Diagnostic variables such as brain scan and measurements from cerebrospinal fluids are also identified as main indicators of encephalitis. Our analysis revealed six major clusters in the England encephalitis data set. However, marked within-cluster heterogeneity is observed in some of the big clusters indicating possible sub-groups. Overall, the results show that patients are clustered according to symptom and diagnostic variables rather than causal agents. Exposure variables such as recent infection, sick person contact and animal contact have been identified as potential risk factors. Conclusions: It is in general assumed and is a common practice to group encephalitis cases according to disease etiology. However, our results indicate that patients are clustered with respect to mainly symptom and diagnostic variables rather than causal agents. These similarities and/or differences with respect to symptom and diagnostic measurements might be attributed to host factors. The idea that characteristics of the host may be more important than the pathogen is also consistent with the observation that for some causes, such as herpes simplex virus (HSV), encephalitis is a rare outcome of a common infection.


    • 3 December 2010
      • Vol. 106  (42) , 21

    Involving patient groups to provide support and information in the care of rare conditions.

    by Susan Bennett, Julia Granerod, Tom Solomon

  • Top Cited Papers
    Open Access

    Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

    by Julia Granerod, Helen E Ambrose, Nicholas Ws Davies, Jonathan P Clewley, Amanda L Walsh, Dilys Morgan, Richard Cunningham, Mark Zuckerman, Ken J Mutton, Tom Solomon, et al.


  • Challenge of the unknown

    by J. Granerod, C.C. Tam, N.S. Crowcroft, N.W.S. Davies, M. Borchert, S.L. Thomas

    The threat of emerging infections and recognition of novel immune-mediated forms of encephalitis has raised the profile of this condition in recent years. Incidence is poorly defined and most cases have an unknown cause. There is currently much interest in identification of new microbial agents of encephalitis, but no work has investigated systematically reasons for lack of pathogen identification in studies. We systematically reviewed published literature on incidence and etiology of encephalitis in non-outbreak settings and explored possible explanations for the large number of cases of unknown etiology. Annual incidence ranged from 0.07 to 12.6 cases per 100,000 population with an evident decrease over time (p = 0.01). The proportion of cases with unknown etiology was high across studies (>50% in 26 of 41 studies), with strong evidence of heterogeneity in study findings (p < 0.001). Our meta-regression identified study period, setting, and subsyndrome to be the main contributors to between-study variation, rather than methodologic factors such as study design, case definitions, sample types, and testing strategies. Our findings support the hypothesis that new and emerging infectious agents, or new forms of immune-mediated encephalitis, may be responsible for cases currently of unknown cause and encourage the ongoing global effort to identify these. Our review highlights research areas that might lead to a better understanding of the causes of encephalitis and ultimately reduce the morbidity and mortality associated with this devastating condition.


  • Causality in acute encephalitis: defining aetiologies

    by J. Granerod, R. Cunningham, M. Zuckerman, K. Mutton, N. W. S. Davies, A. L. Walsh, K. N. Ward, D. A. Hilton, H. E. Ambrose, J. P. Clewley, et al.

    SUMMARY: Defining the causal relationship between a microbe and encephalitis is complex. Over 100 different infectious agents may cause encephalitis, often as one of the rarer manifestations of infection. The gold-standard techniques to detect causative infectious agents in encephalitis in life depend on the study of brain biopsy material; however, in most cases this is not possible. We present the UK perspective on aetiological case definitions for acute encephalitis and extend them to include immune-mediated causes. Expert opinion was primarily used and was supplemented by literature-based methods. Wide usage of these definitions will facilitate comparison between studies and result in a better understanding of the causes of this devastating condition. They provide a framework for regular review and updating as the knowledge base increases both clinically and through improvements in diagnostic methods. The importance of new and emerging pathogens as causes of encephalitis can be assessed against the principles laid out here.


  • Vaccine coverage in England: the impact of health service reorganisation

    by J Granerod, J M White, N Andrews, N S Crowcroft

    Aim: To evaluate the impact of reorganisation of the health service and a change in the definition used to collect immunisation coverage statistics on vaccine coverage data in England. Methods: Denominator data from the Cover Of Vaccination Evaluated Rapidly (COVER) programme, the national programme for the collection of immunisation coverage statistics, were compared to the Office for National Statistics (ONS) population data; the impact of any discrepancies between the two data sources on vaccine coverage was assessed. Results: ONS populations were generally larger than COVER populations. This was particularly true for 2002, the year Primary Care Trusts (PCTs) came into existence, suggesting that some children are being missed by the COVER programme. On average, in 1998–2001 around 10 000 children per year (∼2%) were lost to the COVER population estimates compared to data from ONS. This increased to around 20 000–40 000 (∼3–8%) children in 2002, but decreased again in 2003 to 2000–8000 (∼1%) children. Assuming all the “lost” COVER children were vaccinated, vaccine coverage appeared very similar to that seen in the COVER programme for all antigens. However, assuming all the “lost” children were unvaccinated, coverage would be substantially lower for all antigens (range 2.7–3.5%). Discussion: This analysis provides a quantitative example of how changes such as restructuring of the health service directly impact on public health surveillance. Such changes have potential risks for information and may affect important data used to inform public health policy.


  • Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales

    by J. Granerod, K. L. Davison, M. E. Ramsay, N. S. Crowcroft

    The aims were to (1) investigate the aetiology of probable meningococcal disease, where a clinical diagnosis is made in the absence of laboratory data, and (2) evaluate the impact of the Men C vaccination programme in England and Wales. Multiple linear regression analyses were carried out using data reported to Enhanced Surveillance of Meningococcal Disease (ESMD) and laboratory reports of isolates of organisms causing symptoms that mimic meningococcal disease. Confirmed meningococcal disease appeared to be a significant predictor of probable disease. Thus, an additional reduction in meningococcal disease attributable to the serogroup C vaccination campaign was evident in probable disease over and above that observed in confirmed cases alone. Enteroviruses were a significant contributor to cases of probable meningitis and influenza appeared to be a significant contributor to probable cases of septicaemia. This analysis confirms the success seen following the Men C vaccination campaign and gives an indication of the aetiologies of other causes of probable meningitis and septicaemia reported to ESMD.